Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 6:41 pm Purchase |
2021-12-31 | 13G | Baudax Bio, Inc. BXRX |
ARMISTICE CAPITAL LLC | 6,335 9.990% |
3,233 (+104.20%) |
Filing History |
| 2022-02-14 6:40 pm Purchase |
2021-12-31 | 13G | Globus Maritime Limited GLBS |
ARMISTICE CAPITAL LLC | 1,200,000 5.500% |
1,200,000 (New Position) |
Filing History |
| 2022-02-14 6:38 pm Purchase |
2021-12-31 | 13G | INTELLIPHARMACEUTICS INTL INC IPCI |
ARMISTICE CAPITAL LLC | 3,672,877 9.990% |
1,044,899 (+39.76%) |
Filing History |
| 2022-02-14 6:38 pm Purchase |
2021-12-31 | 13G | Exicure, Inc. XCUR |
ARMISTICE CAPITAL LLC | 74,125 9.990% |
74,125 (New Position) |
Filing History |
| 2022-02-14 6:36 pm Purchase |
2021-12-31 | 13G | Histogen Inc. HSTO |
ARMISTICE CAPITAL LLC | 247,059 9.890% |
247,059 (New Position) |
Filing History |
| 2022-02-14 6:36 pm Purchase |
2021-12-31 | 13G | Spectrum Pharmaceuticals, Inc. SPPI |
ARMISTICE CAPITAL LLC | 9,665,756 5.900% |
73,756 (+0.77%) |
Filing History |
| 2022-02-14 6:35 pm Purchase |
2021-12-31 | 13G | Sadot Group Inc. SDOT |
ARMISTICE CAPITAL LLC | 272,855 9.990% |
272,855 (New Position) |
Filing History |
| 2022-02-14 6:35 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
ARMISTICE CAPITAL LLC | 3,430,154 5.900% |
3,430,154 (New Position) |
Filing History |
| 2022-02-14 6:35 pm Purchase |
2021-12-31 | 13G | ReShape Lifesciences Inc. RSLS |
ARMISTICE CAPITAL LLC | 681 9.990% |
381 (+126.96%) |
Filing History |
| 2022-02-14 6:34 pm Purchase |
2021-12-31 | 13G | The OLB Group, Inc. OLB |
ARMISTICE CAPITAL LLC | 113,761 9.990% |
113,761 (New Position) |
Filing History |
| 2022-02-14 6:33 pm Purchase |
2021-12-31 | 13G | Presidio Property Trust, Inc. SQFT |
ARMISTICE CAPITAL LLC | 1,320,552 9.990% |
1,320,552 (New Position) |
Filing History |
| 2022-02-14 6:33 pm Purchase |
2021-12-31 | 13G | Addex Therapeutics Ltd ADXN |
ARMISTICE CAPITAL LLC | 31,640 9.990% |
31,640 (New Position) |
Filing History |
| 2022-02-14 6:33 pm Sale |
2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
ARMISTICE CAPITAL LLC | 166,667 4.200% |
-52,000 (-23.78%) |
Filing History |
| 2022-02-14 6:31 pm Purchase |
2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
ARMISTICE CAPITAL LLC | 932,052 9.990% |
491,308 (+111.47%) |
Filing History |
| 2022-02-14 6:31 pm Unchanged |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
ARMISTICE CAPITAL LLC | 1,056,000 5.100% |
0 (Unchanged) |
Filing History |
| 2022-02-14 6:31 pm Purchase |
2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
ARMISTICE CAPITAL LLC | 1,124,000 6.600% |
1,124,000 (New Position) |
Filing History |
| 2022-02-14 6:31 pm Purchase |
2021-12-31 | 13G | Energy Focus, Inc. EFOI |
ARMISTICE CAPITAL LLC | 89,674 9.990% |
89,674 (New Position) |
Filing History |
| 2022-02-14 6:29 pm Purchase |
2021-12-31 | 13G | LadRx Corporation LADX |
ARMISTICE CAPITAL LLC | 43,041 9.990% |
43,041 (New Position) |
Filing History |
| 2022-02-14 6:28 pm Sale |
2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
ARMISTICE CAPITAL LLC | 9,572,000 9.300% |
-428,000 (-4.28%) |
Filing History |
| 2022-02-14 6:28 pm Purchase |
2021-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
ARMISTICE CAPITAL LLC | 273,725 9.300% |
273,725 (New Position) |
Filing History |